Codexis (CDXS) Return on Capital Employed Growth (3y) (2014 - 2026)

Codexis (CDXS) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (3y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4,893.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -494.00
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -649.00
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -3,782.00
10 Codexis 135.70 Mn 70.56 Mn 13.18 Mn 193.00

Historic Data

Download Data
DateValue
Mar 31, 2026 193.00
Dec 31, 2025 -1,975.00
Sep 30, 2025 -3,720.00
Jun 30, 2025 -3,860.00
Mar 31, 2025 -4,648.00
Dec 31, 2024 -3,569.00
Sep 30, 2024 -3,978.00
Jun 30, 2024 -4,767.00
Mar 31, 2024 -3,640.00
Dec 31, 2023 -4,662.00
Mar 31, 2023 -1,368.00
Dec 31, 2022 -851.00
Sep 30, 2022 -645.00
Jun 30, 2022 395.00
Mar 31, 2022 615.00
Dec 31, 2021 742.00
Sep 30, 2021 767.00
Jun 30, 2021 2,783.00
Mar 31, 2021 6,043.00
Dec 31, 2020 8,061.00